Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1232.90

-12.60 (-1.01%)

< Home < Back

Dr. Reddys Laboratories informs about press release

Date: 11-08-2020

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 11th August 2020 ‘Dr. Reddy's Laboratories announces the First-to Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.